CHICAGO & SALT LAKE CITY--(BUSINESS WIRE)--Thoughtworks, a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced a strategic ...

ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance ...

Cell-aware diagnosis is a new and effective way to detect defects inside standard cells. Industry standard failure analysis (FA) results from a major foundry show that cell-aware diagnosis is very ...

Atlassian is set to acquire developer intelligence platform DX for approximately $1 billion, aiming to integrate DX's capabilities into its suite of tools like Jira and Bitbucket. This acquisition ...

Atlassian reached a roughly $1 billion deal to buy engineering intelligence firm DX, building a business that aims to help companies understand how artificial intelligence investments can help ...

Atlassian, a provider of team collaboration and productivity software, has entered into a definitive agreement to acquire DX, an engineering intelligence player. Under the agreement, Atlassian will ...

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a cell-engineering focused company announced the acquisition of SeQure Dx. This strategic acquisition strengthens MaxCyte’s ability to serve ex vivo and in ...

MaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...